All Categories - SeekIn
Longevity Medical Institute™ (LMI), Mexico's premier center for regenerative medicine, anti-aging...
BIOS (Pakistan) and OncoInv (The Netherlands) have joined forces to make multi-cancer early...
2025年1月24日 ·
San Diego, January 22, 2025 — SeekIn Inc, a leader in blood-based cancer early detection and...
SAN DIEGO, United States, January 22, 2025 -- SeekIn Inc, aleader in blood-based cancer early...
SAN DIEGO, United States, December 30, 2024 -- SeekIn Inc, a leader in blood-based cancer early...
San Diego, California, USA - November 13-16, 2024 SeekIn Inc., a leader in blood-based cancer...
Amsterdam, The Netherlands - October 26, 2024 Dr. Mao Mao, CEO of SeekIn and a globally...
Chicago, October 15-16, 2024 — At the Precision Oncology & Diagnostics, Bernadette Toner, CEO of...
SeekIn announced a innovative two-step multi-cancer screening strategy at the Early Detection of...
2024年10月15日
OncoInv and Healthcare Systems Mexico have joined forces to make multi cancer early detection...
2024年8月17日 ·
SeekIn Inc., a leader in blood-based cancer early detection and monitoring technology, announced...
Excellion (Nigeria) and OncoInv (The Netherlands) have joined forces to make multi cancer early...
São Paulo, Brazil – First Saúde, led by renowned oncologist Dr. Raphael Brandão, announces a...
In Poland, cancers are detected in late stages, which makes effective treatment impossible....
Two Sample Types, Three Different Platforms, Six Independent Cohorts of ~12,000 Cancer Patients...
NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early...
SeekIn to Grant Oncolnv the Rights to Represent SeekIn’s Comprehensive Range of Cancer Detection...
One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non...
Two Sample Types, Three Different Platforms, Five Independent Cohorts of ~10,000 Cancer Patients...
2023年9月22日 ·
SAN DIEGO, Sept. 21, 2023 /PRNewswire/ -- Monoceros Biosystems, a prominent bioinformatics...